Document Classification

Section Type: RESULTS

Text: Intention to treat analysis showed no significant differences between oral (n = 244) and parenteral (n = 258) treatment, both in the primary outcome (scarring scintigraphy at 12 months 27/197 (13. 7 %) v 36/203 (17. 7 %), difference in risk -4 %, 95 % confidence interval -11. 1 % to 3. 1 %) and secondary outcomes (time to defervescence 36. 9 hours (SD 19. 7) v 34. 3 hours (SD 20), mean difference 2. 6 (-0. 9 to 6. 0) ; white cell count 9. 8 x10 (9) / l (SD 3. 5) v 9. 5 x10 (9) / l (SD 3. 1), mean difference 0. 3 (-0. 3 to 0. 9) ; percentage with sterile urine 185/186 v 203/204, risk difference -0. 05 % (-1. 5 % to 1. 4 %)).